Novel pyrazolopyrimidines as highly potent B-Raf inhibitors

Bioorg Med Chem Lett. 2009 Dec 15;19(24):6957-61. doi: 10.1016/j.bmcl.2009.10.058. Epub 2009 Oct 28.

Abstract

A novel series of pyrazolo[1,5-a]pyrimidines bearing a 3-hydroxyphenyl group at C(3) and substituted tropanes at C(7) have been identified as potent B-Raf inhibitors. Exploration of alternative functional groups as a replacement for the C(3) phenol demonstrated indazole to be an effective isostere. Several compounds possessing substituted indazole residues, such as 4e, 4p, and 4r, potently inhibited cell proliferation at submicromolar concentrations in the A375 and WM266 cell lines, and the latter two compounds also exhibited good therapeutic indices in cells.

MeSH terms

  • Antineoplastic Agents / chemistry*
  • Antineoplastic Agents / pharmacology
  • Cell Line, Tumor
  • Cell Proliferation / drug effects
  • Enzyme Inhibitors / chemistry*
  • Enzyme Inhibitors / pharmacology
  • Humans
  • Proto-Oncogene Proteins B-raf / antagonists & inhibitors*
  • Pyrazoles / chemistry*
  • Pyrazoles / pharmacology
  • Pyridines / chemistry*
  • Pyridines / pharmacology
  • Pyrimidines / chemistry*
  • Pyrimidines / pharmacology

Substances

  • Antineoplastic Agents
  • Enzyme Inhibitors
  • Pyrazoles
  • Pyridines
  • Pyrimidines
  • pyrazolo(3,4-b)pyridine
  • Proto-Oncogene Proteins B-raf